Browse Studies — Arctuva

Phase 1

A Prospective, Open-Label Study Evaluating the Effectiveness of Rimegepant ODT or Zavegepant Nasal Spray for Acute Treatment of Migraine in the Emergency Department

Prospective, single-site, open-label, non-controlled pilot study consisting of two parallel trials. Participants will receive rimegepant or zavegepant for acut…

MigraineMigraine DiseaseMigraine in Adults+4 more

Estimated

~$500 – $7,500

Actual pay is set by the research site.

University of South FloridaNCT07667621

Phase 3

Cessation of Migraine Headaches With Patent Foramen Ovale-Directed Therapy (COMFORT - PFO): An Investigator-Initiated Study

Migraine is a common and often disabling condition, but its exact causes are not fully understood. Some people with migraines have a small opening in the heart…

Migraine DiseasePatent Foramen Ovale

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Columbia UniversityNCT07629635

Observational

A Randomized, Sham Supplement- and Care-as-Usual-Controlled Study to Evaluate Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study

The purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and b…

MigraineMigraine DiseaseMigraine Disorder+5 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Miracle Wellness LLCNCT07634146